TickerWorth Open the interactive view →

CareTrust REIT, Inc. (CTRE) — Valuation Snapshot

Updated Nov 11, 2026 · REIT · FFO, book-value and yield view · descriptive, not a DCF, not advice

This is a REIT. A free-cash-flow DCF is structurally the wrong lens for property: heavy depreciation and continuous property capex swamp reported free cash flow, which is why REITs are valued on FFO/AFFO, net asset value and dividend yield. We show those lenses instead of a DCF number we would not stand behind.
Price
$38.84
Market cap
$10,007,435,264
52-week high
$43.62
52-week low
$34.74
Currency
USD
Exchange
NYSE

CareTrust REIT, Inc. (CTRE) is a real-estate investment trust, and a free-cash-flow discounted-cash-flow (DCF) model is structurally the wrong lens for one. A REIT's reported free cash flow is swamped by property depreciation and the continuous capital spending that maintaining a portfolio requires, which is why the industry is valued on funds from operations (FFO/AFFO), net asset value and dividend yield instead. We have the data to print a DCF number for CTRE; we don't publish one because it would not mean what it appears to mean. What follows is how a REIT is actually read — descriptive, not a valuation, and not investment advice.

On the numbers we do have, CTRE trades at a recent price of $38.84, a market capitalisation of about $10,007,435,264, sitting 46% of the way up its 52-week range ($34.74–$43.62), on the NYSE.

The standard alternative to a DCF is relative valuation — comparing CTRE's trading multiples against a sector benchmark. Here that gives P/E of 24.4× (cheaper than the peer median of 28.8×); Fwd P/E of 20.7× (cheaper than the peer median of 36.1×); P/B of 1.9× (cheaper than the peer median of 7.1×); P/S of 16.3× (richer than the peer median of 10.2×); EV/EBITDA of 22.1× (richer than the peer median of 20.0×); Dividend yield of 4.0% (in line with the peer median of 3.8%). A cheaper multiple than peers can flag a discount or a market that expects weaker growth; it is a comparison, not a recommendation.

The asset, or book-value, lens is the classic tool for asset-heavy businesses and financials. CTRE shows a price-to-book (P/B) of 1.88 and book value of $20.70 per share. Price-to-book compares the market price to the accounting net-asset value per share; below 1.0 can mean a discount to net assets or that the market is pricing in trouble — descriptive either way, never a buy signal on its own.

Finally, a price-based read — explicitly not a valuation. CTRE is in a mixed trend, trading -11.0% from its 52-week high. Over the past year the stock is +6.5%. Moving-average trend and 52-week position describe where the stock has traded; they say nothing about what it is worth.

To be exact about what this page is not: we are not saying the numbers for CTRE are unavailable. They are, and they are above. We are saying a discounted-cash-flow model is the wrong instrument for this kind of business, and publishing one anyway — because the inputs happen to exist — would be a precise answer to the wrong question. Refusing is the more useful answer, and it is the same rule we apply to every name in this category.

Relative valuation — CTRE vs peers

MultipleCTREPeer median
P/E24.4×28.8×cheaper than
Fwd P/E20.7×36.1×cheaper than
P/B1.9×7.1×cheaper than
P/S16.3×10.2×richer than
EV/EBITDA22.1×20.0×richer than
Dividend yield4.0%3.8%in line with

Sector benchmark (bellwethers, not direct competitors).

Asset / book-value view

Price / book (P/B)
1.88
Book value / share
$20.70

Price-to-book compares the market price to the accounting net-asset value per share. Most useful for asset-heavy businesses, banks and insurers.

Price-based snapshot

50-day avg
$37.28
200-day avg
$39.01
From 52-wk high
-11.0%
1-year momentum
+6.5%

Price-based, not a valuation. Moving-average trend and 52-week position describe where the stock has traded — they say nothing about fair value.

Explore more

Most undervalued stocks (per our valuation) · All valued stocks · Interactive CTRE view

A descriptive, available-data snapshot and relative comparison — NOT a DCF, NOT a price target, and NOT investment advice. TickerWorth is an educational tool, not a licensed investment adviser. Figures are estimates derived from public market data and can be wrong, stale or incomplete.